Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

COVID-19 pandemic dramatically impacted transplantation landscape. Scientific societies
recommend against the use of donors with active SARS-CoV-2 infection. Italian Transplant …

Background A significant increased risk of complications and mortality in
immunocompromised patients affected by COVID-19 has been described. However, the …

The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,
hospitalization and death, and the effects of SARS-CoV-2 vaccines in solid organ transplant …

Background Previous studies have indicated inferior responses to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) vaccination in solid organ transplant (SOT) …

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been associated with a
high risk of adverse outcomes in solid organ transplant (SOT) recipients in the pre …

The immunogenicity of the severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐
2) vaccine was improved by the administration of a third dose. The aim of our retrospective …

Solid organ transplant (SOT) recipients are at high risk for severe coronavirus disease 2019
(COVID‐19). Studies suggest that early intervention with monoclonal antibody (MAB) …

Background A fourth dose of SARS-CoV-2 vaccine is recommended in solid-organ
transplant (SOT) recipients, but the immunogenicity is poorly known. Methods We conducted …